Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Mannkind Corp (MNKD)

Mannkind Corp (MNKD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 1,109,784
  • Shares Outstanding, K 270,679
  • Annual Sales, $ 198,960 K
  • Annual Income, $ -11,940 K
  • 60-Month Beta 1.28
  • Price/Sales 5.51
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade MNKD with:

Options Overview Details

View History
  • Implied Volatility 54.64% ( -7.39%)
  • Historical Volatility 59.44%
  • IV Percentile 35%
  • IV Rank 17.22%
  • IV High 289.00% on 07/31/23
  • IV Low 5.89% on 06/12/23
  • Put/Call Vol Ratio 1.61
  • Today's Volume 839
  • Volume Avg (30-Day) 797
  • Put/Call OI Ratio 0.25
  • Today's Open Interest 89,882
  • Open Int (30-Day) 89,294

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate 0.02
  • Number of Estimates 3
  • High Estimate 0.02
  • Low Estimate 0.01
  • Prior Year -0.04
  • Growth Rate Est. (year over year) +150.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
3.97 +2.77%
on 04/17/24
5.11 -20.16%
on 03/25/24
-0.54 (-11.69%)
since 03/18/24
3-Month
3.17 +28.71%
on 02/05/24
5.40 -24.44%
on 03/08/24
+0.73 (+21.79%)
since 01/18/24
52-Week
3.17 +28.71%
on 02/05/24
5.75 -29.04%
on 08/09/23
-0.18 (-4.23%)
since 04/18/23

Most Recent Stories

More News
MannKind (MNKD) Q4 2023 Earnings Call Transcript

MNKD earnings call for the period ending December 31, 2023.

MNKD : 4.08 (-0.49%)
MannKind (MNKD) Q3 2023 Earnings Call Transcript

MNKD earnings call for the period ending September 30, 2023.

MNKD : 4.08 (-0.49%)
MannKind: Q3 Earnings Snapshot

MannKind: Q3 Earnings Snapshot

MNKD : 4.08 (-0.49%)
Why MannKind Stock Soared 19% Higher on Tuesday

The biotech delivered quite an impressive earnings report.

MNKD : 4.08 (-0.49%)
MannKind (MNKD) Q2 2023 Earnings Call Transcript

MNKD earnings call for the period ending June 30, 2023.

MNKD : 4.08 (-0.49%)
MannKind: Q2 Earnings Snapshot

MannKind: Q2 Earnings Snapshot

MNKD : 4.08 (-0.49%)
Why Shares of MannKind Are Up Wednesday

The company released its first-quarter earnings report on Tuesday.

MNKD : 4.08 (-0.49%)
MannKind (MNKD) Q1 2023 Earnings Call Transcript

MNKD earnings call for the period ending March 31, 2023.

MNKD : 4.08 (-0.49%)
MannKind (MNKD) Reports Q1 Loss, Tops Revenue Estimates

MannKind (MNKD) delivered earnings and revenue surprises of 20% and 8.68%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

MNKD : 4.08 (-0.49%)
RPTX : 3.02 (-5.92%)
MannKind: Q1 Earnings Snapshot

MannKind: Q1 Earnings Snapshot

MNKD : 4.08 (-0.49%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 24% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Mannkind Corporation is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases such as diabetes, cancer, inflammatory and autoimmune diseases. The Company's lead product, the Technosphere Insulin System, consists of the Company's dry-powder...

See More

Key Turning Points

3rd Resistance Point 4.35
2nd Resistance Point 4.29
1st Resistance Point 4.18
Last Price 4.08
1st Support Level 4.01
2nd Support Level 3.95
3rd Support Level 3.84

See More

52-Week High 5.75
Fibonacci 61.8% 4.76
Fibonacci 50% 4.46
Fibonacci 38.2% 4.16
Last Price 4.08
52-Week Low 3.17

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar